Rodin Therapeutics Patents – Insights & Stats (Updated 2023)

Rodin Therapeutics has a total of 40 patents globally, out of which 14 have been granted. Of these 40 patents, more than 77% patents are active. Japan is where Rodin Therapeutics has filed the maximum number of patents, followed by Argentina and Taiwan. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of Rodin Therapeutics. Rodin Therapeutics is the subpart of Alkermes was founded in the year 2013. The Company operates as a biotechnology company and develops therapeutics for neurological disorders. Do read about some of the most popular patents of Rodin Therapeutics which have been covered by us in this article and also you can find Rodin Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Rodin Therapeutics patent portfolio.

How many patents does Rodin Therapeutics have?

Rodin Therapeutics has a total of 40 patents globally. These patents belong to 7 unique patent families. Out of 40 patents, 31 patents are active.

How Many Patents did Rodin Therapeutics File Every Year?

Rodin Therapeutics Patents Filing Trend Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or Grant Rodin Therapeutics Applications Filed

Rodin Therapeutics Patents Granted

2023 1 4
2022 7
2021 1 2
2020 5 1
2019 9
2018 19
2016 4
2015 1

How many Rodin Therapeutics patents are Alive/Dead?

Worldwide Patents Rodin Therapeutics Patents Portfolio

How Many Patents did Rodin Therapeutics File in Different Countries?

Rodin Therapeutics Worldwide Patents

Countries in which Rodin Therapeutics Filed Patents

Country Patents
Japan 4
Argentina 3
Taiwan 3
Singapore 2
China 2
Mexico 2
Hong Kong (S.A.R.) 2
South Africa 2
India 2
Israel 2
Korea (South) 2
Eurasia 1
Australia 1
United States Of America 1
Brazil 1
New Zealand 1
Macao 1

Where are Research Centers of Rodin Therapeutics Patents Located?

The research center of all the Rodin Therapeutics patents is the United States of America.

Best Rodin Therapeutics Patents

WO2017007756A1 is the most popular patent in the Rodin Therapeutics portfolio. It has received 49 citations so far from companies like Gedeon Richter Plc, Otsuka Pharmaceutical and American Loden Medical Corporation.

What Percentage of Rodin Therapeutics US Patent Applications were Granted?

Rodin Therapeutics (Excluding its subsidiaries) has filed 12 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 10 have been granted leading to a grant rate of 90.9%. Below are the key stats of Rodin Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Rodin Therapeutics?

Law Firm Total Applications Success Rate
Mccarter & English Llp 12 90.91%

What are Rodin Therapeutics key innovation segments?

What Technologies are Covered by Rodin Therapeutics?

The chart below distributes patents filed by Rodin Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Rodin Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Rodin Therapeutics search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by Rodin Therapeutics?

Table of Content

Insights you may find interesting

Related Articles

Pavegen Patents – Insights & Stats (Updated 2024)

Pavegen has a total of 36 patents globally, out of which 26 have been granted. Of these 36 patents, more than 47% patents are active. United Kingdom is where Pavegen has filed the maximum number of patents, followed by Europe (EPO) and Austria. Parallelly, United Kingdom seems to be the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.